Useful bacteria

BioGaia

BioGaia develops, markets and sells probiotic products. Probiotics are useful bacteria that have documented positive health effects in the body. The applications for BioGaia products are mainly in gastrointestinal, oral and immune health and the products are available in a variety of different types of bottles. Sales are mainly through distribution partners in pharmacies worldwide. The company has two business areas: Pediatrics and Adult Health.

Financials

BIOGAIA

SEKm 2017 2018 2019
Sales 615 706 801
Sales growth (%) 15 14,8 13,4
EBITDA 240 267 285
EBITDA margin (%) 39,1 37,9 35,5
EBIT adj 234 261 277
EBIT adj margin (%) 38 36,9 34,6
Pretax profit 233 261 277
EPS rep 10,48 11,75 12,47
EPS growth (%) -16,1 12,1 6,1
EPS adj 10,48 11,75 12,47
DPS 9 9 9,5
EV/EBITDA (x) 22,2 22,2 20,8
EV/EBIT adj (x) 22,8 22,8 21,4
P/E (x) 31,1 30,8 29
P/E adj (x) 31,1 30,8 29
EV/sales (x) 8,7 8,4 7,4
FCF yield (%) 3,5 2,6 3
Dividend yield (%) 2,8 2,5 2,6
Net IB debt/EBITDA -1,3 -1,2 -1,2

Main shareholders

BioGaia

Main shareholders Share capital % Voting shares %
Peter Rotschild & Jan Annwall 7.2 % 33.0 %
Swedbank Robur Fonder 9.4 % 6.8 %
Fjärde AP-fonden 7.6 % 5.5 %
Sebastian Jahreskog 6.9 % 5.0 %
David Dangoor 3.0 % 2.2 %
Juno Investment Partners 2.4 % 1.7 %
Didrik Hamilton 1.4 % 1.0 %
Tredje AP-fonden 1.4 % 1.0 %
Dimensional Fund Advisors 1.3 % 0.9 %
Allianz Global Investors 1.3 % 0.9 %